Mariam S. Darsot, a chemist by training, is the chairman and chief executive officer of Nexus Pharmaceuticals. Ms. Darsot formed Nexus Pharmaceuticals in 2003 and has been Chairman and CEO since inception. In her role Ms. Darsot is responsible for directing the company's global strategy, business development and key growth initiatives.
Before starting Nexus Pharmaceuticals, Ms. Darsot was a manager at GeoAnalytical Laboratories in Cleveland, Ohio. Prior to that, she worked for GTEL Laboratories, Westech Laboratories and Triangle Laboratories in various analytical chemist roles.
Ms. Darsot holds a Masters in Organic Chemistry from Miami University, in Oxford, Ohio.
Shahid Ahmed joined Nexus Pharmaceuticals in 2007. A chemist by training, Mr. Ahmed has spent his career helping pharmaceutical companies develop new and generic products and spearhead them through the FDA approval process.
Before joining Nexus Pharmaceuticals, he served as vice president of regulatory affairs at American Pharmaceutical Partners, a division of Fresinius Kabi, where he was responsible for obtaining FDA approval of over 40 Abbreviated New Drug Applications (ANDAs). He also held a series of positions at Ben Venue Laboratories, a Division of Boehringer Ingelheim, including vice president of regulatory affairs, quality control and microbiology, where he was responsible for obtaining FDA approval of 51 ANDAs and one NDA. Prior to that, he served in technical, scientific and management roles in research and development with Sanofi Winthrop Pharmaceuticals, Steris Laboratories, Glaxo and Warner Lambert.
Mr. Ahmed holds a Masters in Analytical Chemistry from Manitoba University
Before returning any product to Nexus Pharmaceuticals, Inc. customers must first call the Nexus Pharmaceuticals, Inc. Customer Service Department and obtain a Return Authorization (“RA”) number. All products returned to Nexus Pharmaceuticals, Inc. without an RA number will be refused.
Nexus Pharmaceuticals, Inc. will issue authorization for the return of eligible, unopened product only: (no partial containers. Except in GA, MS & NC)
Eligible Products for Return
Non-Eligible Products for Return
To obtain authorization to return product for credit, please call Nexus Pharmaceuticals, Inc. Customer Service 888 - 806-4606 with the following information:
Nexus Pharmaceuticals, Inc. Customer Service Department will provide an RA number for those items approved for credit. All returns must have the RA number clearly marked on the outside parcel, include shipping and debit memo documentation, and be returned with any goods. No product will be accepted for return without an RA number.
Unauthorized returns may be destroyed and not reimbursed. Nexus Pharmaceuticals, Inc. reserves the right to inspect all authorized returns prior to issuing credit and to destroy products deemed unfit for sale whether or not they are eligible for credit.
Nexus Pharmaceuticals works with a number of authorized distributors. For more information about becoming an authorized distributor, call (888) 806-4606